Wednesday, January 9, 2019

A Millionaire Couple is Threatening to Create a Magic Mushroom Monopoly

    In her article, Olivia Goldhill discusses the how the company, Compass Pathways is promoting the use of psilocybin, the psychedelic compound in magic mushrooms as a treatment for depression. Recent studies have found that psilocybin makes a promising treatment for mental health issues like post traumatic stress disorder, addiction, and depression. Some experts are troubled by the company’s business stricture. Compass Pathways started out as a charity, but became a for-profit corporation just one year later. These critics allege that Compass Pathways has relied on conventional pharmaceutical industry tactics that could help them dominate the field. Compass Pathways denies all the allegations. To read the full article, click here:<>



| Permalink


Post a comment